Iovance Biotherapeutics Inc (IOVA)
NASDAQ:IOVA
Holding IOVA?
Track your performance easily

Iovance Biotherapeutics (IOVA) Financial Statements

2,958 Followers

Iovance Biotherapeutics Financial Overview

Iovance Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-1.495; its P/E ratio is -7.08; Iovance Biotherapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 58.55M$ 31.11M$ 715.00K$ 482.00K$ 469.00K
Gross Profit$ 18.73M$ -262.00K$ -6.55M$ -3.88M$ -3.87M
EBIT$ -85.04M$ -98.60M$ -114.38M-$ -118.36M
EBITDA$ -73.86M$ -85.37M$ -106.82M-$ -108.49M
Net Income Common Stockholders$ -83.54M$ -97.06M$ -113.00M$ -116.35M$ -113.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 397.49M$ 412.54M$ 356.19M$ 279.87M$ 361.37M
Total Assets$ 991.12M$ 964.32M$ 869.83M$ 780.35M$ 852.32M
Total Debt$ 78.94M$ 81.68M$ 84.37M$ 75.86M$ 79.48M
Net Debt$ -318.55M$ -330.86M$ -271.83M$ -204.00M$ -281.90M
Total Liabilities$ 217.66M$ 195.78M$ 189.81M$ 195.74M$ 178.31M
Stockholders Equity$ 773.46M$ 768.54M$ 680.02M$ 584.61M$ 674.01M
Cash Flow-
Free Cash Flow$ -61.29M$ -98.84M$ -126.47M-$ -87.66M
Operating Cash Flow$ -59.00M$ -98.40M$ -122.30M$ -83.97M$ -84.08M
Investing Cash Flow$ -48.80M$ 40.22M$ -111.51M$ -72.84M$ -79.01M
Financing Cash Flow$ 41.95M$ 152.82M$ 193.58M$ 962.00K$ 202.80M
Currency in USD

Iovance Biotherapeutics Earnings and Revenue History

Iovance Biotherapeutics Debt to Assets

Iovance Biotherapeutics Cash Flow

Iovance Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis